Clinical trials
Ischemic clinical trials
Below are recruiting ischemic clinical trials, each written for real people, not researchers. We’re tracking 834 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06994975RecruitingPhase 3
Stroke drug test for patients who missed the 4.5 hour window
This trial tests a clot-busting drug for people who had a stroke more than 4.5 hours ago. It uses a special CT scan to see if the treatment can still help them.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07003113Recruiting
Blood flow therapy for knee and back pain
This study tests a treatment called ischemic preconditioning, which uses a blood pressure cuff to temporarily restrict blood flow to your leg. It may help reduce pain from osteoarthritis in the knee or chronic back pain.
Chicago, IllinoisAges 50 years+ - NCT07026318Recruiting
Combining clot removal and tirofiban for stroke
This trial tests adding the anti-clotting drug tirofiban to standard clot removal for people who have a stroke due to a narrowed artery in the brain. The goal is to see if this combination improves outcomes without raising bleeding risk.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07043686Recruiting
Cerebrolysin for early stroke recovery
This trial tests if adding Cerebrolysin to standard rehabilitation helps people recover arm and hand function better after a first-time, moderate stroke. You may be eligible if you had a stroke and can follow simple instructions.
LjubljanaAges 18 years+ - NCT07069452Recruiting
Predicting recovery after stroke with brain scan scores
This study looks at how well different scores from brain scans can predict recovery after a stroke. It is for people who had an ischemic stroke and were treated with both clot-dissolving medicine and a clot removal procedure.
GonesseAges 18 years+ - NCT07094763Recruiting
Tenecteplase for posterior stroke 4.5-24 hours after onset
This trial tests a clot-busting drug called tenecteplase for people who had a stroke affecting the back part of the brain (posterior circulation). It may be an option if you can get treatment between 4.5 and 24 hours after symptoms started.
HefeiAges 18–100 - NCT07096687Recruiting
Cooling treatment for acute ischemic stroke
This trial tests whether lowering body temperature (targeted temperature management) can help people who have had a stroke within the last 48 hours. It focuses on strokes caused by a blockage in a specific part of the brain's blood supply, and aims to see if cooling can reduce brain damage.
Bologna, BolognaAges 18 years+ - NCT07113041Recruiting
Brain stimulation and robot balance training after stroke
This study tests if adding a gentle brain stimulation (TMS) to robot-assisted balance training helps improve balance after a stroke. It is for people who had a stroke at least 6 months ago and still have trouble with balance.
West Orange, New JerseyAges 18–75 - NCT07119021RecruitingPhase 4
Ultra-early stroke treatment with neuroprotection and clot removal
This trial tests a new approach for treating acute ischemic stroke within 4.5 hours of symptoms starting. It combines a special mobile stroke unit that delivers early brain-protecting medicine with standard clot-busting or clot-removal procedures, to see if this can improve recovery.
BeijingAges 18–80 - NCT07127484Recruiting
Blood filtering for severe stroke
This trial tests whether filtering inflammatory substances from the blood using a special device can improve recovery in people with severe ischemic stroke. You must be within 48 hours of stroke onset and have significant disability or large areas of brain injury.
Wuhu, AnhuiAges 18–80 - NCT07135089RecruitingPhase 3
Tirofiban before clot removal for large artery stroke
This trial tests whether adding a clot-preventing medication called tirofiban before a mechanical clot removal procedure can improve recovery in people with a certain type of stroke. It's for those with a large artery blockage in the front part of the brain who are able to start the procedure within 12 hours.
Shenyang, LiaoningAges 18 years+ - NCT07139301Recruiting
Timing of blood thinners after stroke clot removal in atrial fibrillation
This study aims to find the best time to start blood thinners after emergency clot removal in people with atrial fibrillation who had a stroke. It may help reduce the risk of another stroke or bleeding.
Ma’anshan, AnhuiAges 18 years+ - NCT07139314Recruiting
Timing of blood thinners after stroke clot removal
This trial is testing the best time to start blood thinners (anticoagulation) after emergency stroke treatment in people who have atrial fibrillation. It is for patients who had a certain type of bleeding in the brain after the procedure.
Ma’anshan, AnhuiAges 18 years+ - NCT07167550RecruitingPhase 3
Testing Dimephosphon for recent ischemic stroke recovery
This study tests an investigational drug called Dimephosphon to see if it helps people recover from a recent ischemic stroke (a stroke caused by a clot). It is for adults ages 35–80 whose symptoms began 24 to 72 hours ago and who have not received clot-busting treatments.
Vsevolozhsk, Leningradskaya Oblast'Ages 35–80 - NCT07171242Recruiting
Stroke patient registry study
This study is a registry that collects information from people who have had an ischemic stroke (a type of stroke caused by a blocked blood vessel in the brain). By tracking this information, researchers hope to better understand the condition and improve care for future patients.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07174505Recruiting
Study of the CONDA Stent Retriever for stroke patients
This trial tests a device called the CONDA Stent Retriever to remove blood clots in people having a severe stroke caused by a blockage in a large brain artery. It may help if you can be treated within 24 hours of symptoms starting and meet specific brain scan and health criteria.
BudapestAges 18–85 - NCT07185022Recruiting
Clot-busting drug through artery for medium-vessel stroke
This trial tests a clot-busting drug given directly into the arteries of the brain for people who have had a stroke due to a blockage in a medium-sized artery. It aims to see if this treatment can help improve recovery when started up to 72 hours after symptoms begin.
Fuyang, AnhuiAges 18 years+ - NCT07192211RecruitingPhase 2
Study of ADR-002K for Heart Failure Patients Having Bypass Surgery
This study tests an experimental drug (ADR-002K) for people with heart failure caused by blocked arteries who are about to have bypass surgery. The goal is to see if it helps the heart recover better after surgery.
Osaka, SuitaAges 18–80 - NCT07201688RecruitingPhase 3
Extending the window for stroke clot-busting drug
This trial tests a clot-dissolving medication called rhTNK-tPA for people who had a stroke 4.5 to 24 hours ago. It aims to help those with certain types of blockages in the brain who are still having moderate to severe symptoms.
Puyang, HenanAges 18 years+ - NCT07205328RecruitingPhase 2
Testing MT200605 for acute ischemic stroke
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
Beijing, Beijing MunicipalityAges 18–80 - NCT07232498Recruiting
Early ultrasound-guided movement after a stroke
This trial tests if starting supervised mobility early (within 48 hours) using Doppler ultrasound to guide care can help recovery in adults who just had a stroke caused by a clot. It may help you avoid complications and regain function sooner.
Coimbra, Coimbra DistrictAges 18 years+ - NCT07241520RecruitingPhase 3
Testing SHPL-49 injection for recent stroke patients
This trial tests a new medication, SHPL-49, given as an injection to people who have just had a stroke caused by a blood clot (ischemic stroke). It is for patients who are already receiving standard clot-busting treatment within 8 hours of symptoms starting. The study will see if adding this drug helps improve recovery.
Linfen, ShanxiAges 18–80 - NCT07242768Recruiting
Long-term exercise follow-up for artery narrowing
This trial looks at the long-term effects of regular exercise for people with narrowed brain arteries. It follows participants from a previous study to see if exercise continues to help over three more years.
BeijingAges 40–80 - NCT07247838Recruiting
Gut bacteria changes in first-time stroke patients
This study looks at how gut bacteria change right after a first-time ischemic stroke. It aims to understand if these changes are linked to recovery or other health factors.
Nantong, JiangsuAges 18 years+
Hear when a new Ischemic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ischemic?
- Yes. Clin2 currently lists 834 recruiting ischemic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ischemic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ischemic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.